Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1326–1331. doi: 10.1054/bjoc.2001.2060

An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case–control study

H Tsukada 1, Y Kurita 1, A Yokoyama 1, S Wakai 2, T Nakayama 3, M Sagawa 4, H Misawa 5
PMCID: PMC2375248  PMID: 11720469

Abstract

Although an annual screening programme for lung cancer has been carried out widely in Japan since 1987, there is insufficient evidence to confirm its efficacy in terms of reducing mortality. In order to evaluate the efficacy of the lung cancer screening which has been widely carried out in Japan since 1987, a case–control study was conducted in Niigata Prefecture, Japan. In the study area, chest X-ray examinations for all participants and sputum cytology for high-risk participants were offered annually. Case subjects, who had died from lung cancer (174), and control subjects matched by sex, year of birth, residence and smoking status (801), who had been alive at the time of diagnosis of the corresponding case, were selected from the National Health Insurance holders. Screening histories of the subjects were compared between cases and matched controls for the identical calendar period before the time of diagnosis of the cases. The odds ratio of death from lung cancer for those screened within 12 months vs those not screened was 0.401 (95% CI: 0.272–0.591) with adjustment by smoking index. Our results suggest that annual lung cancer screening might reduce mortality from lung cancer by approximately 60%. © 2001 Cancer Research Campaign

Keywords: lung cancer, screening, case–control study, efficacy

Full Text

The Full Text of this article is available as a PDF (54.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clarke E. A., Anderson T. W. Does screening by "Pap" smears help prevent cervical cancer? A case-control study. Lancet. 1979 Jul 7;2(8132):1–4. doi: 10.1016/s0140-6736(79)90172-7. [DOI] [PubMed] [Google Scholar]
  2. Cole P., Morrison A. S. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980 May;64(5):1263–1272. [PubMed] [Google Scholar]
  3. Cronin K. A., Weed D. L., Connor R. J., Prorok P. C. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst. 1998 Apr 1;90(7):498–504. doi: 10.1093/jnci/90.7.498. [DOI] [PubMed] [Google Scholar]
  4. Dodge R. Sensitivity of methacholine testing in occupational asthma. Chest. 1986 Mar;89(3):324–325. doi: 10.1378/chest.89.3.324. [DOI] [PubMed] [Google Scholar]
  5. Ebeling K., Nischan P. Screening for lung cancer--results from a case-control study. Int J Cancer. 1987 Aug 15;40(2):141–144. doi: 10.1002/ijc.2910400202. [DOI] [PubMed] [Google Scholar]
  6. Ebeling K., Nischan P., Zellmer C. Uberlebensraten beim Bronchialkarzinom in Abhänggkeit von der Art der Erfassung. Arch Geschwulstforsch. 1987;57(1):61–67. [PubMed] [Google Scholar]
  7. Faivre J., Tazi M. A., El Mrini T., Lejeune C., Benhamiche A. M., Dassonville F. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer. 1999 Feb;79(3-4):680–683. doi: 10.1038/sj.bjc.6690107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fontana R. S., Sanderson D. R., Woolner L. B., Taylor W. F., Miller W. E., Muhm J. R. Lung cancer screening: the Mayo program. J Occup Med. 1986 Aug;28(8):746–750. doi: 10.1097/00043764-198608000-00038. [DOI] [PubMed] [Google Scholar]
  9. Henschke C. I., McCauley D. I., Yankelevitz D. F., Naidich D. P., McGuinness G., Miettinen O. S., Libby D. M., Pasmantier M. W., Koizumi J., Altorki N. K. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999 Jul 10;354(9173):99–105. doi: 10.1016/S0140-6736(99)06093-6. [DOI] [PubMed] [Google Scholar]
  10. Hosek R. S., Flanders W. D., Sasco A. J. Bias in case-control studies of screening effectiveness. Am J Epidemiol. 1996 Jan 15;143(2):193–201. doi: 10.1093/oxfordjournals.aje.a008729. [DOI] [PubMed] [Google Scholar]
  11. Kubik A., Parkin D. M., Khlat M., Erban J., Polak J., Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer. 1990 Jan 15;45(1):26–33. doi: 10.1002/ijc.2910450107. [DOI] [PubMed] [Google Scholar]
  12. Melamed M. R., Flehinger B. J. Detection of lung cancer: highlights of the Memorial Sloan-Kettering Study in New York City. Schweiz Med Wochenschr. 1987 Sep 26;117(39):1457–1463. [PubMed] [Google Scholar]
  13. Sobue T., Suzuki T., Naruke T. A case-control study for evaluating lung-cancer screening in Japan. Japanese Lung-Cancer-Screening Research Group. Int J Cancer. 1992 Jan 21;50(2):230–237. doi: 10.1002/ijc.2910500212. [DOI] [PubMed] [Google Scholar]
  14. Tsukada H., Yokoyama A., Kurita Y., Misawa H. [Evaluation of population-based lung cancer screening in Niigata and analysis of interval cases based on comparison lung cancer registry with screening records]. Nihon Kokyuki Gakkai Zasshi. 2000 Jul;38(7):501–508. [PubMed] [Google Scholar]
  15. Weiss N. S., Lazovich D. Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome. Am J Epidemiol. 1996 Feb 15;143(4):319–322. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES